Editorial Policies

Aims and Scope

The Regional Anesthesia and Acute Pain Management Journal is intended for practicing anesthetists.
The aims of the journal are (1) to disseminate information on the modern techniques of regional anesthesia and analgesia used in surgery, modern medications and treatment schemes used to alleviate postoperative pain and (2) to facilitate experience exchange among anesthetists from across Russia and other countries. The journal publishes polemical articles; reviews of, and comments on, clinical cases; lectures; and reviews by the leading specialists in the field of regional anesthesia and pain management.

 
 

Peer Review Process

Content selection

Upon receipt of the manuscript, the executive secretary of the editorial board checks the design of the manuscript.

Authors of manuscripts that do not meet our requirements will receive a template email without detailing the claims. If the manuscript will be received again without appropriate formatting (in accordance with guidelines for authors), it will be rejected.

In case of the appropriate format of a manuscript, the editorial board will make a decision on the compliance of the manuscript with the science profile of the journal.

The accepted manuscript will be sent to the reviewers.

Peer-review

All manuscripts submitted to the Editorial Board of the journal are subject to mandatory double-blind peer review (reviewer does not receive information about the authors of the manuscript, the authors of the manuscript do not receive information about the reviewers).

  1. Review of manuscripts is carried out by members of the Editorial Board and the Editorial Council, as well as by invited reviewers — leading experts in the relevant field. The decision on the choice of a reviewer for the examination of the article is made by the editor-in-chief, Deputy editor-in-chief, Executive Secretary. The review Period is 4 weeks, but at the request of the reviewer it can be extended.
  2. Each reviewer has the right to refuse the review in case of a clear conflict of interest affecting the perception and interpretation of the manuscript. Following the review of the manuscript, the reviewer gives recommendations on the future of the manuscript (each decision of the reviewer must be justified):
  • to accept the manuscript for publication in the present form;
  • to accept the manuscript for publication after correcting the shortcomings noted by the reviewer;
  • to reject the manuscript;
  • to submit the manuscript to the journal of another profile.
  1. The editorial Board of the journal sends the text of reviews to the author. If there are recommendations for revision of the manuscript, the editorial Board proposes to take them into account when preparing a new version of the manuscript.
  2. In case of disagreement with any recommendations (comments) in the response letter to the reviewers, the authors need to clearly argue the reason for the refusal to make the appropriate corrections (additions).
  3. Revision of the article should not take more than two months from the date of sending an electronic message to the authors about the need to make changes. The manuscript modified by the author will be re-sent for review.
  4. The authors make out the answers to the reviewers in separate files and upload them to the site as additional ones on the "summary" tab at the User page. In the case of absence of such a file, further work with the manuscript is suspended, and the authors are notified accordingly.
  5. In case of refusal of the authors to finalize the materials, they must notify the editorial Board in writing of their refusal to publish the article. If the authors do not return the revised version after three months from the date of sending the review, the editorial Board removes it from the account even in the absence of information from the authors with the refusal to finalize the article. In such situations, the authors will be notified of the withdrawal of the manuscript from registration in connection with the expiration of the period allotted for revision.
  6. The editorial Board conducts no more than three rounds of review for each manuscript. If after double revision of the manuscript the reviewers or the editorial Board still have significant comments, the editorial Board rejects the manuscript and removes it from registration. In this case, the authors are notified accordingly.
  7. If the author and reviewers have any unsolvable contradictions regarding the manuscript, the editorial Board has the right to send the manuscript for additional review.
  8. The decision to refuse to publish the manuscript is made at a meeting of the editorial Board in accordance with the recommendations of the reviewers. The message about refusal in the publication goes to the author by e-mail, in the letter reviews and the bases for refusal in the publication are given. The manuscript, not recommended by the decision of the editorial Board for publication, is not accepted for re-consideration.
  9. The presence of a positive review is not a sufficient basis for the publication of the article. The final decision on the publication is made by the editorial Board. In conflict situations, the decision is made by the editor-in-chief.
  10. After the editorial Board of the journal decides on the admission of the manuscript for publication, the editorial Board informs the author and indicates the date of publication.
  11. Originals of reviews are kept in the editorial office for at least 5 years.
  12. After the editorial Board of the journal decides on the admission of the manuscript for publication, the editorial Board informs the author and indicates the date of publication.
  13. Originals of reviews are kept in the editorial office for at least 5 years.
  14. Reviews of manuscripts are not published in the public domain and are used only in the internal document circulation of the editorial Board, as well as in communication with the authors.

Reviews of manuscripts are not published in the public domain and are used only in the internal document circulation of the editorial Board, as well as in communication with the authors.

 

Publication Frequency

Frequency: 6 issues per year

 

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

 

Author Self-Archiving

Author Self-Archiving

The journal is compliant with Green Open Access mode (formerly known as Open Self-Archiving) for articles distribution.

Terms and definitions

We use the following terms and definitions:

  • Preprint: An early version of an article prior to the version submitted for publication in a journal. Theses and dissertations are considered to be preprints.
  • SMUR (Submitted Manuscript Under Review): The version of the article that is under formal review for inclusion in the journal.
  • AM (Accepted Manuscript): The version of the article that has been accepted for publication. This version may include revisions resulting from peer review but may be subject to further modification by Pharmarus Print Media (for example, copyediting and typesetting).
  • VoR (Version of Record): The version that is formally published. This not includes any Online First article that is formally identified as being published online before the compilation of a journal issue. The VoR includes any post-publication corrections.
  • Personal webpage: Web pages created by you, about you and your research which are hosted on a non-commercial website (such as your institute’s website). Personal profile pages in commercial sharing sites (such as ResearchGate, Academia.edu and Facebook) are not considered to be personal web pages.
  • Department or institutional repository: Web pages hosted by an academic or research institute or department to provide access to the work to promote and the activities of the institute or department, always operating for a non-commercial purpose.
  • Subject repository: Web pages hosted by an organization to provide access to the work from researchers working in a subject or range of subjects, always operating for a non-commercial purpose.
  • Commercial and non-commercial: Commercial means any activity for direct or indirect financial gain. When considering whether a use is commercial or non-commercial, we look at the nature of the activity rather than the nature of the site or organization performing the activity.

 

What can be self-archived, where, and when

 

 

Personal web page

Department or institutional repository

Non-commercial subject repository

(e.g. PubMed Central)

Commercial repository or social media site

(e.g. ResearchGate, Academia.edu, SSRN)

Preprint, SMUR

At any time

At any time

At any time

At any time

AM

On acceptance

On acceptance

On acceptance

Abstract only plus link to VoR on journal site

VoR

Abstract only plus link to VoR on journal site

Abstract only plus link to VoR on journal site

Abstract only plus link to VoR on journal site

Abstract only plus link to VoR on journal site

 

Plan S compliance

Our Green OA policy is not compatible with Plan S, and our License to Publish agreements with authors may conflict with authors' agreements with their cOAlition S funders. Authors should publish as Gold OA to be compliant with Plan S.

Creative Commons and other end-user licenses

Preprints and SMURs can be made publicly accessible under any license terms the authors choose. We recommend a Creative Commons CC-BY or a more restrictive CC license.

Accepted Manuscripts can be made accessible under a Creative Commons CC-BY-NC-ND license or equivalent, but not a more permissive license. We do not allow AMs to be made accessible under a CC-BY license, for example.

Third-party material

Before posting articles online, authors should ensure they have the appropriate permission to include any third-party content. When posting articles under a Creative Commons license, the permission should allow the third-party material to be included either (i) under the Creative Commons license or (ii) clearly indicated as being protected by third party copyright, with a clear notice that it cannot be reused without further permissions clearance from the identified third-party rights holder.

Closed deposits and embargo periods

Articles can be deposited in repositories before publication provided the content is only accessible to repository administration staff. This is sometimes referred to as ‘closed deposit’.

Metadata about the article (for example the article title, abstract, and journal citation) can be made public as soon as the article is published. The full text must not be made public before the embargo ends.

Any applicable embargo period starts from the date the Version of Record is first published online as part of a journal’s issue.

Posting content in repositories

We require repositories to include:

  • If an article has not yet been published, a clear statement that the material has been accepted for publication in a revised form, with a link to the journal’s site
  • For all published articles, a link to the article’s Version of Record in journal site – for example, via a DOI-based link.
  • A clear statement about the license terms under which the posted version of the article is deposited.

Example statements are:

  • This article has been published in a revised form in ………[http://doi.org/XXX]. This version is free to view and download for private research and study only. Not for re-distribution or re-use. © copyright holder.
  • This article has been published in a revised form in ……….[http://doi.org/XXX]. This version is published under a Creative Commons CC-BY-NC-ND. No commercial re-distribution or re-use allowed. Derivative works cannot be distributed. © copyright holder.


Citing content in repositories

When citing an Accepted Manuscript or an earlier version of an article, we request that readers also cite the Version of Record with a DOI link, for example: Subsequently published in revised form in ………[http://doi.org/XXX].

 

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 230.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

 

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 35.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

 

Editor rejection

Reasons for rejection of manuscripts by the editor without transfer to reviewers:

  • The design of the manuscript does not meet the requirements of the journal;
  • the manuscript does not meet the criteria of any of the journal section;
  • the volume of the manuscript significantly exceeds the maximum allowable one;
  • the materials of the manuscript do not contain illustrative material, statistical analysis of the results obtained, or are presented in an exceptionally concise form, which does not allow assessing the quality of the presented material.
  • Correspondence author ORCID profile does not content publicly available information.

 

Publishing Ethics

The Ethic policy of "Regional Anesthesia and Acute Pain Management" journal is based on recomendations from international commettees:

Reporting standarts

The Regional Anesthesia and Acute Pain Management journal editorial team ask authors of reports of original research to present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Review and professional publication articles should also be accurate and objective, and editorial opinion works should be clearly identified as such.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Authorship clarified

The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.

The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines (based on ICMJE guidelines):

All authors whose names appear on the submission:

  1. made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work AND
  2. drafted the work or revised it critically for important intellectual content AND
  3. approved the version to be published AND
  4. agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Anyone who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their permission.

Submissions by anyone other than one of the authors will not be considered.

Research Ethics and Patient Consent (Statement of Human and Animal Rights)

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

Hazards for Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the authors should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

When reporting experiments on animals, authors have to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Research involving human embryos, gametes, and stem cells

Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations (See also Research involving human participants and/or animals)

The manuscript should include an ethics statement identifying the institutional and/or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that informed consent (See also Informed consent) was obtained from all recipients and/or donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the Journal.

We encourage authors to follow the principles laid out in the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation.

In deciding whether to publish papers describing modifications of the human germline, the Journal is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. In case of concerns regarding a particular type of study the Journal may seek the advice from the Springer Nature Research Integrity Group.

The decision to publish a paper is the responsibility of the Editor-in-Chief of the Journal.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').

Conflicts of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Conflicts include the following:

  • Financial — funding and other payments, goods and services received or expected by the authors relating to the subject of the work or from an organization with an interest in the outcome of the work;
  • Affiliations — being employed by, on the advisory board for, or a member of an organization with an interest in the outcome of the work;
  • Intellectual property — patents or trademarks owned by someone or their organization;
  • Personal — friends, family, relationships, and other close personal connections;
  • Ideology — beliefs or activism, for example, political or religious, relevant to the work;
  • Academic — competitors or someone whose work is critiqued.

For more information on conflicts of interest, see the guidance from the ICMJE and WAME.

Funding and Acknowledgement of Sources

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/  

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Plagiarism

Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Only original works are acceptable for publication in "Regional Anesthesia and Acute Pain Management" journal. The journal does not allow any forms of plagiarism. Authors must not use the words, figures, or ideas of others without attribution. All sources must be cited at Regional Anesthesia and Acute Pain Management journal take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. All the submitted articles are evaluated with plagiarism-checking software (Antiplagiat). Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgment, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to:

  • publishing an erratum or corrigendum (correction);
  • retracting the article;
  • taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies;
  • or taking appropriate legal action.

Also you can see ORI Avoiding Plagiarism, Self-plagiarism, and Other Questionable Writing Practices: A Guide to Ethical Writing

Duplicate Submission and Redundant Publication

Regional Anesthesia and Acute Pain Management journal consider only original content, i.e. articles that have not been previously published, including in a language other than English. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered.

Manuscripts submitted to Regional Anesthesia and Acute Pain Management journal must not be submitted elsewhere while under consideration and must be withdrawn before being submitted elsewhere. Authors whose articles are found to have been simultaneously submitted elsewhere may incur sanctions.

If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they must cite the previous articles and indicate how their submitted manuscript differs from their previous work. Reuse of the authors’ own words outside the Methods should be attributed or quoted in the text. Reuse of the authors’ own figures or substantial amounts of wording may require permission from the copyright holder and the authors are responsible for obtaining this.

Regional Anesthesia and Acute Pain Management journal will consider extended versions of articles published at conferences provided this is declared in the cover letter, the previous version is clearly cited and discussed, there is significant new content, and any necessary permissions are obtained.

Redundant publication, the inappropriate division of study outcomes into more than one article (also known as salami slicing), may result in rejection or a request to merge submitted manuscripts, and the correction of published articles. Duplicate publication of the same, or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Citation Manipulation

Authors whose submitted manuscripts are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal, may incur sanctions.

Editors and reviewers must not ask authors to include references merely to increase citations to their own or an associate’s work, to the journal, or to another journal they are associated with.

Fundamental errors in published works, Corrections and Retractions

When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the authors’ institution(s). 

Errors by the authors may be corrected by a corrigendum, and errors by the publisher — by an erratum (see more).

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice.

Sanctions

If Regional Anesthesia and Acute Pain Management journal becomes aware of breaches of our publication ethics policies, the following sanctions may be applied:

  • Rejection of the manuscript and any other manuscripts submitted by the author(s).
  • Not allowing submission for 1–3 years.
  • Prohibition from acting as an editor or reviewer.

Regional Anesthesia and Acute Pain Management journal may apply additional sanctions for severe ethical violations.

 

Editor rejection

Reasons for rejection of manuscripts by the editor without transfer to reviewers:

  • The design of the manuscript does not meet the requirements of the journal;
  • the manuscript does not meet the criteria of any of the journal section;
  • the volume of the manuscript significantly exceeds the maximum allowable one;

the materials of the manuscript do not contain illustrative material, statistical analysis of the results obtained, or are presented in an exceptionally concise form, which does not allow assessing the quality of the presented material.

 

Attribution of authorship

Editorial board emphasize that:

Only those persons who have made a significant contribution to the conception of the work, the development, execution, and/or interpretation of the results of the presented study, as well as to the process of writing the manuscript (including scientific and stylistic editing and design in accordance with the requirements of the journal) may be recognized as the Authors of the publication.

When submitting a manuscript to the journal, Authors shall ensure that:

  • All participants who made a significant contribution to the reported study are presented as Co-Authors;
  • Those who did not participate in the study are not listed as Co-Authors;
  • All Co-Authors have read and approved the final version of the paper and agreed to its submission for publication—this shall be confirmed by the signatures of all Authors in the cover letter.

Identification of illegal borrowings is carried out:

  • as part of scientific peer review;
  • through the ANTI-PLAGIARISM system.

At this stage of expertise:

  • The editors do not take into account the percentage of originality calculated by the anti-plagiarism program;
  • The editors relies only on an expert analysis of the full report of the program;
  • The editors allow for complete coincidence in the description of the applied research methods with such in previously published articles, textbooks, manuals.;
  • The editors believe that the introduction, results, discussion and conclusion (conclusions) should be completely original.

If conclusions coincide with those formulated earlier by other researchers, this should be explicitly indicated in the manuscript in the discussion section.

 

Authors Conflicts of Interest Disclosure form

All Authors must disclose in their manuscript ― declare in the appropriate section of the manuscript ― any financial or other relevant interests that might be construed to influence the findings or interpretation of their research.

Examples of potential conflicts of interest to be disclosed are given below:

  • Receiving financial rewards for participating in the research or writing of a manuscript;
  • Any affiliation (contract work, consulting, equity assets, fees, and expert opinions) with organizations that have a direct interest in the subject matter of the research or review;
  • A patent application or registration for research findings (copyright, etc.);
  • Receiving financial support for any of the stages of conducting the research or writing a manuscript (including grants and other forms of financial support).

Information on conflicts of interest received from the Authors of manuscripts should be available only to the Editorial Board when deciding whether to publish the manuscript. Such information on conflicts of interest shall then be published as part of the full text of the paper.

When writing this part of the manuscript, the Publisher recommends using the interactive form available at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf

A Reviewer shall not participate in the review of manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with any of the Authors, companies, or other organizations related to the submitted paper.

Editors recuse themselves from reviewing manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with Authors, companies, and possibly other organizations related to the manuscript.

 

Retraction

Retraction’s reasons

The retraction of an already published article is an extreme measure and is applied in the event of the disclosure of facts that were not known during the review.

Reasons for retraction are as follows:

  • detection of incorrect borrowings (plagiarism) in the publication;
  • duplication of the article in several publications;
  • detection of falsifications or fabrications in the work (for example, manipulation of experimental data);
  • detection of serious errors in the work (for example, misinterpretation of the results), which calls into question its scientific value;
  • detection of persons who do not meet the criteria for authorship;
  • a conflict of interest was not announced;
  • article was republished without the consent of the author;
  • the article has not been peer reviewed.

Retraction procedure:

  • Authors, readers, reviewers, editors, and the Publisher can initiate a retraction of a paper by application to the editorial office of the Journal.
  • The Retraction Commission reviews the received application and notifies the interested parties about the beginning of the retraction procedure.
  • The Retraction Commission decides to retract the published paper if there are sufficient facts in favor of retraction.
  • The Retraction Commission notifies the initiator of the retraction of the paper about the results of consideration in written form.
  • If the commission decides to retract the paper, the Journal publishes information that the paper has been retracted, including the metadata of the retracted paper.
  • If papers from the Journal are indexed by any databases, a letter is sent to these databases stating that this paper has been retracted, indicating the reasons for retraction.
  • The editorial board has the right to independently decide on additional sanctions – for example, on the inclusion of authors in the blacklist of the Journal for a certain period, or indefinitely.

 

Appeal

The Editorial Board may grant Authors the right to appeal editorial decisions on the acceptance or rejection of papers.

The protocol of actions of the Editorial Board in case of receiving an appeal shall be described on the journal’s website.

Appeal Mechanism

  1. If the Author does not agree with the decision of the Editorial Board on the acceptance or rejection of the paper, the Author may appeal to the Editorial Board in writing, clearly indicating the reasons for the appeal.
  2. The Author’s appeal shall be considered by the Conflict Resolution Commission.
  3. The Editorial Board may change its decision in the following cases:
  • The Author provided additional findings that were not considered in the initial review of the paper.
  • The Author provided additional materials to the manuscript, which were not considered during the initial review of the paper.
  • The Author provided information on the conflict of interest, which was not provided during the initial review of the paper.
  • The Author expressed concern about a biased review.
  1. If there are sufficient grounds, the Conflict Resolution Commission shall make a proposal to the Editorial Board to change or uphold the initial decision on the publication of the paper.
  2. If necessary, the Editorial Board may engage an additional Reviewer to make the final decision.
  3. The decision on the acceptance or rejection of the paper based on the results of the revision of the primary decision shall be made by the Editorial Board.
  4. The decision of the Editorial Board based on the results of the revision of the primary decision shall be final and not subject to re-appeal.

 

Issues upload

Published articles are sent to the Scientific electronic libraries (eLibrary.ru) within three weeks after publication of all language versions at the official journal site.

 

Post-publishing changes

As part of the policy of post-publishing changes, the following types of articles are published in the journal.

Clarification

A variety of Erratum. The article does not report errors but clarifies the data of a previously published article.

Comment

Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.

Correspondence

Letter to the editor or a reply to the letter.

Correction

An article describing the corrections made in an article previously published in the same journal. This type of publication is not a variant of Erratum.

Corrigendum

Article in which errors are reported that were made by authors in an earlier publication in the same journal.

Duplicate

Accidental duplication of an article in another Eco-Vector's journal. The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is a duplicate.

Editorial

Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance t

Erratum

Article in which errors are reported that were made in an earlier publication in the same journal. Can be Erratum (publishing error) but also Corrigendum (author error).

Expression of Concern

A notification about the integrity of a published article that is typically written by an editor and should be labelled prominently in the item title. It is the responsibility of the editor to initiate appropriate investigative procedures, discover the outcome of the investigation, and notify readers of that outcome in a subsequent published item. The outcome may require the publication of a retraction notice.

Removal

Editorial notice of the removal of a previously published article.

The text of the article is removed. The HTML pages and PDF pages of the article are completely removed and replaced by a single page with citation details and an explanation.

Retracted publication

The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is retracted.

Retraction of Publication

Editorial notice of the retraction of a previously published article.

Withdrawal

Refutation of an article previously published in the same journal (in a situation where retraction cannot be performed).

For details see Crossmark Policy.

 

Advertising policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

  1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
  4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
  • Alcohol
  • Tobacco
  • Weapons, firearms, ammunition
  • Fireworks
  • Gambling and lottery
  • Pornography or related themes
  • Political and religious advertisements
  • Advertisements that claim to have a “miracle” cure or method
  • Advertisements that make unsubstantiated health claims for the products advertised
  • Advertisements directed at children
  1. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  2. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  3. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  4. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  5. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  6. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  7. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  8. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  9. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  10. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  11. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  12. The following online advertising formats are prohibited:
  • Pop-ups and floating advertisements.
  • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
  • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
  • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/

 

Authors' payment

There are several authors fees for the journal:

  • Fast Track (optional);
  • Open access (optionsal).

 

Marketing

The publisher of the journal provides following open access options to the content of the electronic version of the journal to the following categories:

  • Members of the editorial board - non-expirable;
  • the authors of the published papers - for one year from publication data;
  • Organizations founders of the journal - non-expirable;
  • Organizations to which anniversary thematic issues are dedicated - one-year/

Readers and authors of the journal can connect to the RSS feed to receive up-to-date information about the journal.

As part of scientific and practical events (conferences, symposiums), participants are provided with a free copy of the journal.

The publisher does not send requests to potential authors to submit manuscripts.

The publisher provides an opportunity for reviewers to submit a review to Publons.

 

Manuscript submission

If you have read the editorial policy and found that the results of your research correspond to the subject of the journal, you may get to the manuscript submission page.

 

Accepted manuscripts

The accepted manuscript is submitted to the scientific editor. From this moment on, the authors are strictly prohibited from making any changes to the text of the manuscript without the consent of the scientific editor.

After agreeing on all changes with the scientific editor, the authors will have to upload the final version of the manuscript to their personal account on the website (Word file).

At the next stage, the manuscript will be handed over to the layout editor to create an electronic layout of the article.

This file (proofreading) will be sent to the authors in pdf format for final approval.

 

Manuscript withdrawal

Authors can withdraw their manuscript at any stage of consideration and preparation for publication (including in electronic form on the website in Online First mode).

Withdrawal procedure

The author's team sends a letter to the official address of the editorial office with a request to withdraw the manuscript from consideration or publication, indicating the reason. The letter must contain a scanned appeal of the author's team with the signatures of all co-authors (PDF).

The editorial board notifies the authors of the receipt of the letter.

Within a week, the Editorial Board notifies the authors of the withdrawal of the manuscript from consideration or the termination of its preparation for publication and moves the manuscript to the electronic archive by means of the editorial and publishing platform.

If the authors have not received a response from the editorial board within a week, then you should contact the publisher or the editor-in-chief of the journal, attaching the correspondence.

If, despite sending messages to the editorial office, the publisher and the editor-in-chief, the article being withdrawn was published in the journal (including it was published electronically on the website in Online First mode), the withdrawal of the manuscript is possible only through the retraction procedure (see Retraction).

 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies